{
    "2019-08-27": [
        [
            {
                "time": "",
                "original_text": "刘氏兄妹控股高达九成五 维康药业二冲IPO多名供应商屡上黑榜 产品问题",
                "features": {
                    "keywords": [
                        "刘氏兄妹",
                        "控股",
                        "维康药业",
                        "IPO",
                        "供应商",
                        "黑名单",
                        "产品问题"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "马太效应显现 零售药店并购踩刹车",
                "features": {
                    "keywords": [
                        "马太效应",
                        "零售药店",
                        "并购",
                        "踩刹车"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "零售",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}